Why is hyperglycaemia worsening COVID-19 and its prognosis?
作者信息
Ceriello Antonio, De Nigris Valeria, Prattichizzo Francesco
机构信息
IRCCS MultiMedica, Milan, Italy.
Insititut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
出版信息
Diabetes Obes Metab. 2020 Oct;22(10):1951-1952. doi: 10.1111/dom.14098. Epub 2020 Jun 21.
Abstract
摘要
相似文献
1
Why is hyperglycaemia worsening COVID-19 and its prognosis?
Diabetes Obes Metab. 2020 Oct;22(10):1951-1952. doi: 10.1111/dom.14098. Epub 2020 Jun 21.
2
Admission fasting blood glucose predicts 30-day poor outcome in patients hospitalized for COVID-19 pneumonia.
Diabetes Obes Metab. 2020 Oct;22(10):1955-1957. doi: 10.1111/dom.14132. Epub 2020 Aug 4.
3
Prognostic Value of Hyperglycemia and Insulin Resistance Among Patients with Confirmed COVID-19 Infections at Admission to the Alexandria Fever Hospital, Egypt.
Metab Syndr Relat Disord. 2024 Sep;22(7):551-557. doi: 10.1089/met.2024.0066. Epub 2024 Apr 29.
4
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
Diabetes Obes Metab. 2020 Oct;22(10):1897-1906. doi: 10.1111/dom.14099. Epub 2020 Jun 30.
5
Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
Mediators Inflamm. 2021 Mar 18;2021:8812304. doi: 10.1155/2021/8812304. eCollection 2021.
6
Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?
Lancet Diabetes Endocrinol. 2021 Jun;9(6):328-329. doi: 10.1016/S2213-8587(21)00087-5. Epub 2021 Apr 7.
7
COVID-19 and diabetes: the contributions of hyperglycemia.
J Mol Cell Biol. 2020 Sep 7;12(12):958-962. doi: 10.1093/jmcb/mjaa054.
8
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Front Endocrinol (Lausanne). 2021 Jun 17;12:649525. doi: 10.3389/fendo.2021.649525. eCollection 2021.
9
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
10
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):725-727. doi: 10.1016/j.dsx.2020.05.037. Epub 2020 May 27.
引用本文的文献
1
The Impact of SARS-CoV-2 Infection on Glucose Homeostasis in Hospitalized Patients with Pulmonary Impairment.
Diagnostics (Basel). 2025 Feb 25;15(5):554. doi: 10.3390/diagnostics15050554.
2
COVID-19 and diabetes research: Where are we now and what does the future hold? A bibliometric visualization analysis.
Heliyon. 2024 Sep 10;10(18):e37615. doi: 10.1016/j.heliyon.2024.e37615. eCollection 2024 Sep 30.
3
The relationship between COVID-19 and hyperglycemia: screening and monitoring hospitalized patients.
Clin Diabetes Endocrinol. 2024 Aug 31;10(1):29. doi: 10.1186/s40842-024-00184-7.
4
The prognostic significance of insulin resistance in COVID-19: a review.
J Diabetes Metab Disord. 2024 Jan 20;23(1):305-322. doi: 10.1007/s40200-024-01385-8. eCollection 2024 Jun.
5
Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients.
Egypt J Med Hum Genet. 2021;22(1):82. doi: 10.1186/s43042-021-00207-3. Epub 2021 Nov 26.
6
Covid-19-Associated Mucormycosis: Histopathology of the Deadly Fungal Infection.
Int Arch Otorhinolaryngol. 2024 Jan 24;28(2):e240-e246. doi: 10.1055/s-0043-1776729. eCollection 2024 Apr.
7
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes?
J Clin Med. 2024 Mar 24;13(7):1874. doi: 10.3390/jcm13071874.
8
Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients.
Biomedicines. 2024 Feb 19;12(2):467. doi: 10.3390/biomedicines12020467.
9
Epidemiology, Clinical Profile, and Analysis of Risk Factors in COVID Associated Rhino-orbito-cerebral Mucormycosis Patients - An Observational Study.
Indian J Endocrinol Metab. 2023 Nov-Dec;27(6):519-523. doi: 10.4103/ijem.ijem_372_22. Epub 2024 Jan 11.
10
Decreased cardiovascular risk factors and inflammation with remission of type 2 diabetes in adults with obesity using a high protein diet: Randomized control trial.
Obes Pillars. 2022 Dec 1;4:100047. doi: 10.1016/j.obpill.2022.100047. eCollection 2022 Dec.
本文引用的文献
1
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
Diabetes Obes Metab. 2020 Oct;22(10):1897-1906. doi: 10.1111/dom.14099. Epub 2020 Jun 30.
2
The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.
Diabetes Obes Metab. 2020 Aug;22(8):1443-1454. doi: 10.1111/dom.14086. Epub 2020 Jun 17.
3
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
Int J Mol Sci. 2020 May 10;21(9):3377. doi: 10.3390/ijms21093377.
4
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
J Med Virol. 2020 Jul;92(7):770-775. doi: 10.1002/jmv.25887. Epub 2020 Apr 27.
5
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.
Diabetes Metab Res Rev. 2020 Oct;36(7):e33213321. doi: 10.1002/dmrr.3321. Epub 2020 Apr 13.
6
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.
Acta Diabetol. 2010 Sep;47(3):193-9. doi: 10.1007/s00592-009-0109-4. Epub 2009 Mar 31.
7
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S9-13. doi: 10.1016/j.jacc.2008.09.054.
8
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.
Arterioscler Thromb Vasc Biol. 2004 May;24(5):816-23. doi: 10.1161/01.ATV.0000122852.22604.78. Epub 2004 Feb 19.
9
Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.
Diabetologia. 1993 Nov;36(11):1119-25. doi: 10.1007/BF00401055.
Zotero 插件